Jaguar Health, Inc. (NASDAQ:JAGX)

BRIEF

published on 06/26/2024 at 14:35, 4 months 27 days ago

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement

Crofelemer Jaguar Health Nasdaq Compliance OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 06/26/2024 at 14:30, 4 months 27 days ago

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
JAGX's securities remain listed and traded on Nasdaq as Jaguar announces regaining compliance with Nasdaq's bid price requirement. Updates on cancer supportive care drug crofelemer OnTarget trial results expected by July 23, 2024

Crofelemer Nasdaq Jaguar Health OnTarget Trial JAGX
BRIEF

published on 06/21/2024 at 22:20, 5 months 2 days ago

Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders

Crofelemer Podcast Jaguar Health OnTarget Trial World Rainforest Day
PRESS RELEASE

published on 06/21/2024 at 22:15, 5 months 2 days ago

Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
Jaguar Health, Inc. to report pivotal phase 3 OnTarget trial results for cancer supportive care drug crofelemer by July 23, 2024. Investor webcast and podcast interview updates included

Crofelemer Investor Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
BRIEF

published on 06/12/2024 at 14:35, 5 months 11 days ago

Jaguar Health to Announce Pivotal Phase 3 OnTarget Trial Results by July 23, 2024

Crofelemer Investor Webcast Jaguar Health Phase 3 OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 06/12/2024 at 14:30, 5 months 11 days ago

Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
Jaguar Health, Inc. to discuss updates on cancer supportive care portfolio in investor webcast, focusing on CTD and oral mucositis. Details on pivotal phase 3 OnTarget trial for crofelemer

Investor Webcast Jaguar Health Inc. Oral Mucositis Cancer Supportive Care CTD
BRIEF

published on 06/07/2024 at 22:20, 5 months 16 days ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Restricted Stock Units Compensation Nasdaq Jaguar Health
PRESS RELEASE

published on 06/07/2024 at 22:15, 5 months 16 days ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. granted 1,111 RSUs to a new employee, subject to one-year vesting. The RSUs were approved by the Compensation Committee

Restricted Stock Units Employee Benefits Jaguar Health Inc. RSUs Compensation Committee
BRIEF

published on 05/29/2024 at 14:35, 5 months 25 days ago

Jaguar Health Executes Out-License Deal for Botanical Drug Candidate for Schizophrenia

Jaguar Health Magdalena Biosciences Schizophrenia Botanical Drug Out-License Deal
PRESS RELEASE

published on 05/29/2024 at 14:30, 5 months 25 days ago

Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jaguar announces expansion of out-licensing agreement with Magdalena Biosciences for Botanical Drug Candidate targeting schizophrenia market. Company to present at Lytham Partners Spring 2024 Investor Conference

Jaguar Health Magdalena Biosciences Lytham Partners Spring 2024 Investor Conference Out-licensing Agreement Schizophrenia Market

Published on 11/22/2024 at 23:55, 1 day 3 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 4 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 4 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 4 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 5 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 9 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 9 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 9 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 10 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 11 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 13 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 20 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 9 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 9 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News